ANI Pharmaceuticals (ANIP)

[kcccole]

ANIP is going down on extremely low volume. This indicates no one is really convinced the next earnings report will be good. After not hitting estimates the last two quarters institutions are taking a wait and see approach. The share price has collapsed after the two last earnings reports and lots of investors are still remember that so they are not willing to put new money at risk. Short sellers are also not convinced now is a good time to cover. Everyone is just waiting.

I do not agree with JTFM that a lack of investor presentations/conferences indicate a quite period for Libigel. I have listened to every earnings CC and I have never heard anyone ask any questions about Libigel. Why a quiet period when no one asks anyway? Studies have indicated that in the long run investor presentations/conferences do nothing for the stock price. Stock prices increase on an expectation earnings growth will continue into the future. I believe investor conferences could drum up support in the short term.

At this point, investors are not convinced that ANIP can successfully gain FDA approval and market corticotropin nor that there is anything to the Libigel deal with whoever.